drugset / Trial / NCT00604188

A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)

NCT00604188

Phase 4 Completed 188 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the acceptability and safety of Suboxone in heroin users as a replacement therapy for opioid dependency by comparing the clinical response of participants who are inducted directly onto Suboxone with that of participants who are inducted first to Subutex and then transferred to Suboxone.

Timeline

Start
2008-02-22
Primary completion
2009-12-10
Completion
2009-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 8 mg Other
Subject Buprenorphine Other / unclassified 24 mg Other
Subject Naloxone Small molecule 8 mg Other
Subject Naloxone Small molecule 24 mg Other

Indications